Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Automated Microbial Diagnostics01:24

Automated Microbial Diagnostics

Automated diagnostic analyzers have transformed clinical microbiology by providing rapid and reliable methods for pathogen identification and antibiotic susceptibility testing. Among these systems, the Vitek 2 is widely used because it automates the traditionally labor-intensive processes of microbial identification (ID) and antibiotic susceptibility testing (AST), delivering standardized and timely results that are essential for effective patient care.Microbial Identification with ID CardsThe...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Fixed-Bed Bioreactor Culture Enhances Yield and Reparative Properties of hTERT Mesenchymal Stem Cell Extracellular Vesicles.

Cells·2026
Same author

Characterization of <i>Borrelia</i>-Derived Extracellular Vesicles: Implications for Pathogenesis and Diagnostics.

Microorganisms·2026
Same author

Laser capture microdissection.

Nature reviews. Methods primers·2026
Same author

Reproductive risk of Neonicotinoids: A review of male rodent studies.

Environmental research·2025
Same author

Secretory mitophagy: an extracellular vesicle-mediated adaptive mechanism for cancer cell survival under oxidative stress.

Frontiers in cell and developmental biology·2025
Same author

Targeted Dynamic Phospho-Proteogenomic Analysis of Gastric Cancer Cells Suggests Host Immunity Provides Survival Benefit.

Molecular & cellular proteomics : MCP·2024
Same journal

Mapping the 3D Chromosome Organization of a Biosynthetic Gene Cluster by Capture Hi-C (CHi-C).

Methods in molecular biology (Clifton, N.J.)·2026
Same journal

Mapping the 3D Chromosome Organization of Streptomyces by Hi-C.

Methods in molecular biology (Clifton, N.J.)·2026
Same journal

CUT&Tag Epigenomic Profiling of Biosynthetic Gene Clusters in Arabidopsis thaliana.

Methods in molecular biology (Clifton, N.J.)·2026
Same journal

Rhizobium rhizogenes-Mediated Hairy Root Transformation Protocol for Lotus japonicus and Other Legumes.

Methods in molecular biology (Clifton, N.J.)·2026
Same journal

Characterization of Bioactive Saponins from Sea Cucumbers.

Methods in molecular biology (Clifton, N.J.)·2026
Same journal

Methods for Functional Validation of Terpenoid Metabolic Clusters in Nicotiana benthamiana and Aspergillus oryzae.

Methods in molecular biology (Clifton, N.J.)·2026
See all related articles

Related Experiment Video

Updated: May 27, 2026

Employing Digital Droplet PCR to Detect BRAF V600E Mutations in Formalin-fixed Paraffin-embedded Reference Standard Cell Lines
10:16

Employing Digital Droplet PCR to Detect BRAF V600E Mutations in Formalin-fixed Paraffin-embedded Reference Standard Cell Lines

Published on: October 8, 2015

Small business development for molecular diagnostics.

Anthanasia Anagostou1, Lance A Liotta

  • 1Tatari Design Center and Zorba Marketing Incorporated, Alexandria, VA, USA.

Methods in Molecular Biology (Clifton, N.J.)
|November 15, 2011
PubMed
Summary
This summary is machine-generated.

Molecular diagnostics enables personalized medicine through early disease detection and companion diagnostics. This review guides business development and commercialization strategies for molecular diagnostic products.

More Related Videos

Multiplexed Isothermal Amplification Based Diagnostic Platform to Detect Zika, Chikungunya, and Dengue 1
06:18

Multiplexed Isothermal Amplification Based Diagnostic Platform to Detect Zika, Chikungunya, and Dengue 1

Published on: March 13, 2018

Related Experiment Videos

Last Updated: May 27, 2026

Employing Digital Droplet PCR to Detect BRAF V600E Mutations in Formalin-fixed Paraffin-embedded Reference Standard Cell Lines
10:16

Employing Digital Droplet PCR to Detect BRAF V600E Mutations in Formalin-fixed Paraffin-embedded Reference Standard Cell Lines

Published on: October 8, 2015

Multiplexed Isothermal Amplification Based Diagnostic Platform to Detect Zika, Chikungunya, and Dengue 1
06:18

Multiplexed Isothermal Amplification Based Diagnostic Platform to Detect Zika, Chikungunya, and Dengue 1

Published on: March 13, 2018

Area of Science:

  • Biotechnology
  • Molecular Medicine
  • Healthcare Business

Background:

  • Molecular profiling, utilizing molecular diagnostics on tissue and blood, is key to modern molecular medicine and personalized therapies.
  • Molecular diagnostics offers significant opportunities for small businesses in the healthcare sector.
  • Current demands include early disease detection with enhanced sensitivity/specificity and companion diagnostics for tailored treatments.

Purpose of the Study:

  • To review the opportunities and challenges in developing businesses within the molecular diagnostics field.
  • To provide guidance on creating business models and marketing strategies for molecular diagnostic products.
  • To outline commercialization steps using case studies of existing companies.

Main Methods:

  • Review of business development principles applied to molecular diagnostics.
  • Analysis of market demands in healthcare for molecular diagnostic products.
  • Case study examination of successful molecular diagnostics companies.

Main Results:

  • Molecular diagnostics facilitates early disease detection and patient stratification for targeted therapies.
  • Business models and marketing plans are crucial for commercializing molecular diagnostic products.
  • Commercialization pathways involve strategic planning and learning from established industry players.

Conclusions:

  • Molecular diagnostics presents a promising area for business innovation in personalized medicine.
  • Strategic business development and marketing are essential for successful commercialization.
  • Learning from existing companies can inform the pathway to market for new molecular diagnostic ventures.